We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Loss of Neuronal Enzyme Underlies Rare Childhood Epileptic Encephalopathy

By Gerald M. Slutzky, PhD
Posted on 08 Dec 2016
A recessive mutation causing loss of an enzyme required for neuronal development was shown to underlie a rare form of childhood epileptic encephalopathy.

Epileptic encephalopathy, which is often linked to improper development of the brain, is a rare but devastating sub-form of epilepsy that results in severe mental and physical disabilities in children from birth. More...
To better understand the genetic and mechanistic causes of this disease, investigators at McGill University (Montreal, Canada) and collaborators in Canada, Saudi Arabia, Jordan, and Germany performed whole exome sequencing on three children with epileptic encephalopathy from two families, one from Saudi Arabia and another from Jordan.

The investigators reported in the November 17, 2016, online edition of the American Journal of Human Genetics that epileptic encephalopathy, which featured cerebral calcifications and coarse facial features, was caused by recessive loss-of-function mutations in the gene DENND5A.

DENND5A contains a DENN domain, an evolutionarily ancient enzymatic module conferring guanine nucleotide exchange factor (GEF) activity to multiple proteins serving as GEFs for Rab proteins, which are key regulators of membrane trafficking. DENND5A is detected predominantly in neuronal tissues, and its highest levels occur during development. Knockdown of DENND5A leads to striking alterations in neuronal development.

Mechanistically, changes caused by lack of DENND5A activity appeared to result from upregulation of neurotrophin receptors, leading to enhanced downstream signaling. Neurotrophins are a family of proteins involved in the survival, development, and function of neurons.

"Our study demonstrates the importance of membrane trafficking in neuronal development and it provides a new pathophysiological mechanism for this disease type. This will allow physicians around the world to test if mutations in DENND5A are causing the disease in their patients, and also to provide genetic counseling for affected families," said first author Dr. Chanshuai Han, a neurodegenerative disease researcher at McGill Univesity.

Related Links:
McGill University


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
All-in-One Molecular System
AIO M160
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.